Vaduganathan M, Mensah GA, Turco JV, et al. The Global Burden of Cardiovascular Diseases and Risk: a compass for Future Health. J Am Coll Cardiol. 2022;80(25):2361–71. https://doi.org/10.1016/j.jacc.2022.11.005.

Article  PubMed  Google Scholar 

Wijesurendra RS, Casadei B. Mechanisms of atrial fibrillation. Heart. 2019;105(24):1860–7. https://doi.org/10.1136/heartjnl-2018-314267.

Article  CAS  PubMed  Google Scholar 

Wu TJ, Ong JJ, Chang CM, et al. Pulmonary veins and ligament of Marshall as sources of rapid activations in a canine model of sustained atrial fibrillation. Circulation. 2001;103(8):1157–63. https://doi.org/10.1161/01.cir.103.8.1157.

Article  CAS  PubMed  Google Scholar 

Marrouche NF, Wilber D, Hindricks G, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014;311(5):498–506. https://doi.org/10.1001/jama.2014.3.

Article  CAS  PubMed  Google Scholar 

Oakes RS, Badger TJ, Kholmovski EG, et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation. 2009;119(13):1758–67. https://doi.org/10.1161/CIRCULATIONAHA.108.811877.

Article  PubMed  PubMed Central  Google Scholar 

Rodríguez-Mañero M, Valderrábano M, Baluja A, et al. Validating left atrial low voltage Areas during Atrial Fibrillation and Atrial Flutter using Multielectrode Automated Electroanatomic Mapping. JACC Clin Electrophysiol. 2018;4(12):1541–52. https://doi.org/10.1016/j.jacep.2018.08.015.

Article  PubMed  Google Scholar 

Isomoto S, Konoe A, Centurion OA, et al. Electrophysiological effects of MS-551 in humans: a class III antiarrhythmic agent. Pacing Clin Electrophysiol. 1995;18(11):2022–7. https://doi.org/10.1111/j.1540-8159.1995.tb03863.x.

Article  CAS  PubMed  Google Scholar 

Morita N, Tanaka K, Yodogawa K, et al. Effect of nifekalant for acute conversion of atrial flutter: the possible termination mechanism of typical atrial flutter. Pacing Clin Electrophysiol. 2007;30(10):1242–53. https://doi.org/10.1111/j.1540-8159.2007.00846.x.

Article  PubMed  Google Scholar 

Kumagai K, Toyama H. Usefulness of ablation of complex fractionated atrial electrograms using nifekalant in persistent atrial fibrillation. J Cardiol. 2013;61(1):44–8. https://doi.org/10.1016/j.jjcc.2012.08.015.

Article  PubMed  Google Scholar 

Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372(19):1812–22. https://doi.org/10.1056/NEJMoa1408288.

Article  PubMed  Google Scholar 

Kawaji T, Shizuta S, Yamagami S, et al. Clinical utility of Intravenous Nifekalant Injection during Radiofrequency catheter ablation for Persistent Atrial Fibrillation. J Atr Fibrillation. 2018;11(1):1839. https://doi.org/10.4022/jafib.1839.

Article  PubMed  PubMed Central  Google Scholar 

Di C, Gao P, Wang Q, et al. Intraprocedural Conversion Efficacy of Intravenous Nifekalant Administration for Persistent Atrial Fibrillation after pulmonary vein isolation. Int Heart J. 2020;61(6):1157–64. https://doi.org/10.1536/ihj.20-328.

Article  PubMed  Google Scholar 

Li D, Melnyk P, Feng J, et al. Effects of experimental Heart Failure on atrial cellular and ionic electrophysiology. Circulation. 2000;101(22):2631–8. https://doi.org/10.1161/01.cir.101.22.2631.

Article  CAS  PubMed  Google Scholar 

Workman AJ, Pau D, Redpath CJ, et al. Atrial cellular electrophysiological changes in patients with ventricular dysfunction may predispose to AF. Heart Rhythm. 2009;6(4):445–51. https://doi.org/10.1016/j.hrthm.2008.12.028.

Article  PubMed  Google Scholar 

Su WW, Reddy VY, Bhasin K, et al. Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: results from the multicenter STOP persistent AF trial. Heart Rhythm. 2020;17(11):1841–7. https://doi.org/10.1016/j.hrthm.2020.06.020.

Article  PubMed  Google Scholar 

Yang B, Jiang C, Lin Y, et al. STABLE-SR (electrophysiological substrate ablation in the Left Atrium during Sinus Rhythm) for the treatment of Nonparoxysmal Atrial Fibrillation: a prospective, Multicenter Randomized Clinical Trial. Circ Arrhythm Electrophysiol. 2017;10(11):e005405. https://doi.org/10.1161/CIRCEP.117.005405.

Article  PubMed  Google Scholar 

Zhai Z, Xia Z, Xia Z, et al. Comparison of the efficacy and safety of different doses of nifekalant in the instant cardioversion of persistent atrial fibrillation during radiofrequency ablation. Basic Clin Pharmacol Toxicol. 2021;128(3):430–9. https://doi.org/10.1111/bcpt.13513.

Article  CAS  PubMed  Google Scholar 

Naitoh N, Taneda K, Tagawa M, et al. Electrophysiologic effects of intravenous MS-551, a novel class III antiarrhythmic agent, on human atrium and ventricle. Jpn Heart J. 1998;39(3):297–305. https://doi.org/10.1536/ihj.39.297.

Article  CAS  PubMed  Google Scholar 

Sato S, Zamami Y, Imai T, et al. Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardia. Sci Rep. 2017;7(1):12683. https://doi.org/10.1038/s41598-017-13073-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang M, Zhang S, Sun Q, et al. Effect of nifekalant on acute electrical remodelling in rapid atrial pacing canine model. Chin Med J (Engl). 2006;119(24):2056–61.

Article  CAS  PubMed  Google Scholar 

Masuda M, Konishi S, Asai M, et al. Usefulness of an IKr blocker for ablation of non-pulmonary vein ectopies that are unmappable due to easily initiated atrial fibrillation. J Interv Card Electrophysiol. 2020;58(2):203–8. https://doi.org/10.1007/s10840-019-00590-3.

Article  PubMed  Google Scholar 

Wang M, Zhao Q, Ding W, et al. Comparison of Direct current synchronized cardioversion to Ibutilide-guided catheter ablation for long-term sinus rhythm maintenance after isolated pulmonary vein isolation of Persistent Atrial Fibrillation. Am J Cardiol. 2017;119(12):1997–2002. https://doi.org/10.1016/j.amjcard.2017.03.027.

Article  PubMed  Google Scholar 

Yue L, Feng J, Gaspo R, et al. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res. 1997;81(4):512–25. https://doi.org/10.1161/01.res.81.4.512.

Article  CAS  PubMed  Google Scholar 

Dong Y, Zhai Z, Zhu B, et al. Development and validation of a Novel Prognostic Model Predicting the Atrial Fibrillation recurrence risk for Persistent Atrial Fibrillation patients treated with Nifekalant during the First Radiofrequency catheter ablation. Cardiovasc Drugs Ther. 2022 Jun;22. https://doi.org/10.1007/s10557-022-07353-9.